Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Unlisted holdings
| % of total assets |
|---|
| N/R |
Please note that the percentage of unlisted holdings is displayed for companies that have reported this data to the AIC. “N/R” means the data has not been reported to the AIC. Where data is reported, it may be subject to valuation lags.
Top holdings
Data as at : 30/11/2023
| Investment | % of total assets |
|---|---|
| Collegium | 20.9 |
| Insmed | 13.6 |
| LumiraDx | 11.5 |
| Coherus | 11.4 |
| BioCryst | 11.3 |
| BMS | 7.4 |
| OptiNose | 6.5 |
| UroGen | 4.6 |
| Evolus | 4.6 |
| ImmunoGen | 2.3 |
Geographic breakdown
Data as at : 30/06/2023
| Country | % of total assets |
|---|---|
| United States | 28.4 |
Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.
Industry breakdown
Data as at : 30/06/2023
| Industry | % of total assets |
|---|---|
| Cash Equivalents | 7.7 |
Scroll
Asset breakdown
Data as at : 30/06/2023
| Asset | % of total assets |
|---|---|
| Stock | 88.7 |
| Other | 3.6 |
| Cash/Cash equivalents | 7.7 |
Detailed asset breakdown
Data as at : 30/06/2023
| Asset | % of total assets |
|---|---|
| Other - stock | 60.3 |
| North America - stock | 28.4 |
| Cash | 7.7 |
| Other | 3.6 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
